CClinicalTrials.gg
CompletedNCT02110836Updated Aug 7, 2015

The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.

An interventional study of Glucose ingestion and Sucrose ingestion in Liver and Muscle Glycogen Use During Exercise., sponsored by Javier Gonzalez, PhD. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-07.

Sponsored by Javier Gonzalez, PhD · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

Carbohydrate is stored in the body as glycogen, which is mainly found in the liver and muscle. During endurance exercise, muscle glycogen is used as fuel for the working muscles and liver glycogen is broken down to provide glucose to maintain blood glucose (sugar) levels. Both liver and muscle glycogen are important for the ability to perform intense/prolonged endurance exercise. Therefore, nutritional strategies which can maximise the availability of glycogen in muscle and liver can benefit endurance exercise capacity.

The carbohydrates typically found in sports drinks are glucose and sometimes fructose. If glucose only is ingested during exercise, then the maximum rate at which can be absorbed from the intestine into the blood stream is \~1 g/min. However, if different sources of carbohydrate (fructose) are used, which are absorbed through a different pathway, absorption of carbohydrate can be up to \~1.8 g/min. With more carbohydrate available as a fuel, this translates into an improvement in performance.

Sucrose is a naturally occurring sugar that is made up of a single glucose and single fructose molecule. Therefore, theoretically, this can use the two different pathways of absorption and also maximise carbohydrate delivery. It is not yet known however, what impact this has on our liver and muscle glycogen stores during exercise. Therefore the aim of this study is to assess whether sucrose ingestion influences liver and muscle glycogen depletion during endurance exercise.

02

Conditions studied

  • Liver and Muscle Glycogen Use During Exercise.
03

In context

Lead sponsor

This is the only study on the registry with Javier Gonzalez, PhD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy
  • Male
  • 18 - 35 years of age
  • Endurance trained cyclist/triathlete
  • VO2 max ≥ 50 ml/kg/min

Exclusion criteria

Exclusion Criteria:

  • Use of medication
  • Smoking
  • Metabolic disorders
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Active comparator
    Glucose ingestion

    Glucose ingestion during exercise at a rate of 1.8 g/min.

    Dietary Supplement: Glucose ingestion

  • Experimental
    Sucrose ingestion

    Sucrose ingestion during exercise at a rate of 1.8 g/min.

    Dietary Supplement: Sucrose ingestion

Interventions

  • Dietary supplementGlucose ingestion

    Glucose ingestion during exercise at 1.8 g/min

  • Dietary supplementSucrose ingestion

    Sucrose ingestion during exercise at 1.8 g/min

06

What researchers measure

Primary outcomes

  1. Change in liver glycogen concentration

    The change in liver glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.

    Time frame: 3 hours

Secondary outcomes

  1. Plasma glucose concentration.

    Plasma glucose concentrations will be determined every 30 min during 3 h of exercise.

    Time frame: 3 hours

  2. Plasma lactate concentration

    Plasma lactate concentrations will be determined every 30 min during 3 h of exercise.

    Time frame: 3 hours

  3. Plasma non-esterified fatty acid concentration

    Plasma non-esterified fatty acid concentrations will be determined every 30 min during 3 h of exercise.

    Time frame: 3 hours

  4. Indirect calorimetry

    Measurements of oxygen consumption, carbon dioxide production and respiratory exchange ratio through indirect calorimetry measured every 30 minutes during exercise.

    Time frame: 3 hours

  5. Muscle glycogen concentration

    The change in muscle glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.

    Time frame: 3 hours

  6. Change in intramyocellular lipid concentration

    The change in intramyocellular lipid concentration will be determined pre-to-post 3 h of exercise using 1H magnetic resonance spectroscopy.

    Time frame: 3 hours

07

Study locations

1 site
  • Northumbria University
    Newcastle upon Tyne, Tyne and Wear NE1 8ST, United Kingdom
08

References and documents

Publications

  • Gonzalez JT, Fuchs CJ, Smith FE, Thelwall PE, Taylor R, Stevenson EJ, Trenell MI, Cermak NM, van Loon LJ. Ingestion of glucose or sucrose prevents liver but not muscle glycogen depletion during prolonged endurance-type exercise in trained cyclists. Am J Physiol Endocrinol Metab. 2015 Dec 15;309(12):E1032-9. doi: 10.1152/ajpendo.00376.2015. Epub 2015 Oct 20. PubMed 26487008 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02110836
Lead sponsor
Javier Gonzalez, PhD
Collaborators
University of Newcastle Upon-Tyne, Maastricht University, Sugar Nutrition, UK
Responsible party
Javier Gonzalez, PhD (Research Fellow, Northumbria University) — Sponsor-investigator
First posted
Apr 10, 2014
Start date
Apr 2014
Primary completion
Sep 2014
Completion
Apr 2015
Last update
Aug 7, 2015

Study contacts

Luc van Loon, PhD
principal investigator · Maastricht University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion